Icíar Avilés-Olmos

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 811 citations

Psychotropic Medication, Clinical Trials, Psychopharmacology +8

Exenatide and the treatment of patients with Parkinson’s disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Clinical Investigation · 2013 · 494 citations

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

Icíar Avilés-Olmos, John Dickson, Zinovia Kefalopoulou et al. · Journal of Parkinson s Disease · 2014 · 291 citations · Full text

MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety

Thomas Foltynie, Ludvic Zrinzo, Irene Martínez‐Torres et al. · Journal of Neurology Neurosurgery & Psychiatry · 2010 · 251 citations · Full text

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach

Icíar Avilés-Olmos, Zinovia Kefalopoulou, Elina Tripoliti et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 185 citations · Full text